ATE527238T1 - Mittel mit wirkung gegen sichelzellenanämie - Google Patents
Mittel mit wirkung gegen sichelzellenanämieInfo
- Publication number
- ATE527238T1 ATE527238T1 AT03787240T AT03787240T ATE527238T1 AT E527238 T1 ATE527238 T1 AT E527238T1 AT 03787240 T AT03787240 T AT 03787240T AT 03787240 T AT03787240 T AT 03787240T AT E527238 T1 ATE527238 T1 AT E527238T1
- Authority
- AT
- Austria
- Prior art keywords
- sickle cell
- furfuraldehyde
- cell anemia
- agent against
- against sickle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
- C07D307/48—Furfural
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43068102P | 2002-12-04 | 2002-12-04 | |
US51167103P | 2003-10-17 | 2003-10-17 | |
US51218703P | 2003-10-20 | 2003-10-20 | |
PCT/US2003/038264 WO2004050030A2 (en) | 2002-12-04 | 2003-12-03 | Anti-sickling agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE527238T1 true ATE527238T1 (de) | 2011-10-15 |
Family
ID=32475410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03787240T ATE527238T1 (de) | 2002-12-04 | 2003-12-03 | Mittel mit wirkung gegen sichelzellenanämie |
Country Status (8)
Country | Link |
---|---|
US (1) | US7160910B2 (de) |
EP (2) | EP2179987B1 (de) |
AT (1) | ATE527238T1 (de) |
AU (1) | AU2003296022B2 (de) |
CA (1) | CA2507545C (de) |
ES (2) | ES2407090T3 (de) |
PT (2) | PT1567490E (de) |
WO (1) | WO2004050030A2 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070099237A1 (en) * | 2005-10-31 | 2007-05-03 | The Regents Of The University Of Michigan | Reaction co-crystallization of molecular complexes or co-crystals |
ES2601856T3 (es) | 2007-06-08 | 2017-02-16 | Mannkind Corporation | Inhibidores de la IRE-1A |
WO2011146471A1 (en) * | 2010-05-18 | 2011-11-24 | Aesrx Llc | Treatment for altitudinal hypoxia |
US9918958B2 (en) * | 2011-07-15 | 2018-03-20 | Warren Stern | Treatment for hypoxia |
SG11201403645VA (en) | 2011-12-28 | 2014-07-30 | Global Blood Therapeutics Inc | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
EP2797597B1 (de) | 2011-12-28 | 2020-02-26 | Global Blood Therapeutics, Inc. | Substituierte heteroarylaldehydverbindungen und verfahren zu deren verwendung bei der erhöhung einer gewebeoxigenierung |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
WO2014145040A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
JP2016512821A (ja) * | 2013-03-15 | 2016-05-09 | グローバル ブラッド セラピューティクス インコーポレイテッド | ヘモグロビンの修飾のための組成物及び方法 |
EA033555B1 (ru) | 2013-03-15 | 2019-10-31 | Global Blood Therapeutics Inc | Фармацевтические композиции для лечения серповидно-клеточного нарушения |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
ES2909634T3 (es) | 2013-03-15 | 2022-05-09 | Global Blood Therapeutics Inc | Compuestos y usos de los mismos para la modulación de hemoglobina |
CA2902874C (en) * | 2013-03-15 | 2021-04-20 | Global Blood Therapeutics, Inc. | Substituted pyridinyl-6-methoxy-benzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
AU2014237340C1 (en) | 2013-03-15 | 2018-11-08 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
CA2902711C (en) | 2013-03-15 | 2021-07-06 | Global Blood Therapeutics, Inc. | Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin |
EP3036222A2 (de) * | 2013-08-23 | 2016-06-29 | Virginia Commonwealth University | Esternitratderivate von aromatischen aldehyden mit mehreren pharmalogischen eigenschaften zur behandlung von sichelzellanämie |
US20160206604A1 (en) * | 2013-08-26 | 2016-07-21 | Global Blood Therapeutics, Inc. | Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s) |
EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
AP2016009261A0 (en) | 2014-02-07 | 2016-06-30 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
WO2016043849A2 (en) | 2014-07-24 | 2016-03-24 | Global Blood Therapeutics, Inc. | Compounds for treating acute respiratory distress syndrome or a negative effect thereof |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
WO2017096230A1 (en) | 2015-12-04 | 2017-06-08 | Global Blood Therapeutics, Inc. | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
TWI825524B (zh) | 2016-05-12 | 2023-12-11 | 美商全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
ES2966707T3 (es) | 2018-10-01 | 2024-04-23 | Global Blood Therapeutics Inc | Moduladores de la hemoglobina para el tratamiento de la drepanocitosis |
US10683285B2 (en) | 2018-11-19 | 2020-06-16 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin |
US10836729B1 (en) | 2020-05-04 | 2020-11-17 | King Abdulaziz University | Metabolically stable 5-HMF derivatives for the treatment of hypoxia |
US11458144B1 (en) * | 2021-12-23 | 2022-10-04 | King Abdulaziz University | Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sickling |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1030415A (zh) * | 1987-02-20 | 1989-01-18 | 山之内制药株式会社 | 饱和的杂环碳酰胺衍生物和它的制备方法 |
US5705521A (en) | 1990-02-12 | 1998-01-06 | The Center For Innovative Technology | Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors |
JPH0416821A (ja) | 1990-05-10 | 1992-01-21 | Fujitsu Ltd | 自動光量調節装置 |
US5985880A (en) * | 1996-06-05 | 1999-11-16 | Delta Pharmaceuticals | Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
JP4382166B2 (ja) * | 1996-02-09 | 2009-12-09 | 大正製薬株式会社 | 血流改善剤 |
JPH1117124A (ja) | 1997-06-24 | 1999-01-22 | Toshiba Corp | 半導体装置およびその製造方法 |
US6251927B1 (en) | 1999-04-20 | 2001-06-26 | Medinox, Inc. | Methods for treatment of sickle cell anemia |
CN1114443C (zh) * | 1999-10-29 | 2003-07-16 | 中国科学院上海细胞生物学研究所 | 诱导分化治疗的药物及其应用 |
-
2003
- 2003-12-03 ES ES10152353T patent/ES2407090T3/es not_active Expired - Lifetime
- 2003-12-03 AU AU2003296022A patent/AU2003296022B2/en not_active Ceased
- 2003-12-03 AT AT03787240T patent/ATE527238T1/de not_active IP Right Cessation
- 2003-12-03 CA CA2507545A patent/CA2507545C/en not_active Expired - Fee Related
- 2003-12-03 EP EP10152353A patent/EP2179987B1/de not_active Expired - Lifetime
- 2003-12-03 EP EP03787240A patent/EP1567490B1/de not_active Expired - Lifetime
- 2003-12-03 US US10/725,935 patent/US7160910B2/en not_active Expired - Fee Related
- 2003-12-03 PT PT03787240T patent/PT1567490E/pt unknown
- 2003-12-03 PT PT101523538T patent/PT2179987E/pt unknown
- 2003-12-03 WO PCT/US2003/038264 patent/WO2004050030A2/en not_active Application Discontinuation
- 2003-12-03 ES ES03787240T patent/ES2372047T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2004050030A3 (en) | 2004-07-29 |
US7160910B2 (en) | 2007-01-09 |
US20040157801A1 (en) | 2004-08-12 |
AU2003296022B2 (en) | 2007-01-25 |
EP2179987B1 (de) | 2013-02-13 |
WO2004050030A2 (en) | 2004-06-17 |
EP1567490A4 (de) | 2007-09-05 |
CA2507545A1 (en) | 2004-06-17 |
EP2179987A3 (de) | 2010-07-14 |
AU2003296022A1 (en) | 2004-06-23 |
PT2179987E (pt) | 2013-03-11 |
CA2507545C (en) | 2011-06-21 |
EP2179987A2 (de) | 2010-04-28 |
PT1567490E (pt) | 2011-12-09 |
ES2407090T3 (es) | 2013-06-11 |
EP1567490B1 (de) | 2011-10-05 |
ES2372047T3 (es) | 2012-01-13 |
EP1567490A2 (de) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE527238T1 (de) | Mittel mit wirkung gegen sichelzellenanämie | |
EA200500853A1 (ru) | 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака | |
CY2014028I1 (el) | Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης | |
ECSP066311A (es) | Derivados de la piperazina y su uso como agentes terapéuticos | |
DE60238086D1 (de) | Platelet adp rezeptor inhibitoren | |
CY1108874T1 (el) | ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ | |
CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
CY2015007I1 (el) | Ενωσεις, συνθεσεις και χρησεις παραγωγων βενζοθειαζολης | |
NO20054244D0 (no) | Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel | |
NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
TR200201205T2 (tr) | N-ikame edilmiş karbamoiloksialkil-azolyum türevleri. | |
DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
DK1557415T3 (da) | Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens | |
NO20062629L (no) | Oksazolderivater av tetrackliner | |
ATE416157T1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
NO20052908D0 (no) | Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
BR0313385A (pt) | Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz | |
UY27979A1 (es) | Indoles sustituidos en posición 2,4 | |
WO2004000793A3 (en) | Aminoacetonitrile derivatives suitable for controlling parasites | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
HUP0303701A2 (hu) | Triazintrion-szulfon-származékok alkalmazása kokcidiózis ellen | |
DK1619185T3 (da) | 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |